Solutions

Our AI solutions for cancer detection

VisioCyt® Bladder is a non-invasive test for the diagnosis and follow-up of bladder cancer using a simple urine sample.

Currently in development, VisioCyt® Screening is a test for bladder cancer screening in asymptomatic, high-risk patients.

Currently in development, VisioCyt® Thyroid is a test for the diagnosis of thyroid cancer using a thyroid fine-needle aspiration.